Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
Cancer Discov. 2023 Mar 1;13(3):570-579. doi: 10.1158/2159-8290.CD-22-0764.
UNLABELLED: Molecular features underlying colorectal cancer disparities remain uncharacterized. Here, we investigated somatic mutation patterns by race/ethnicity and sex among 5,856 non-Hispanic white (NHW), 535 non-Hispanic Black (NHB), and 512 Asian/Pacific Islander (API) patients with colorectal cancer (2,016 early-onset colorectal cancer patients: sequencing age <50 years). NHB patients with early-onset nonhypermutated colorectal cancer, but not API patients, had higher adjusted tumor mutation rates than NHW patients. There were significant differences for LRP1B, FLT4, FBXW7, RNF43, ATRX, APC, and PIK3CA mutation frequencies in early-onset nonhypermutated colorectal cancers between racial/ethnic groups. Heterogeneities by race/ethnicity were observed for the effect of APC, FLT4, and FAT1 between early-onset and late-onset nonhypermutated colorectal cancer. By sex, heterogeneity was observed for the effect of EP300, BRAF, WRN, KRAS, AXIN2, and SMAD2. Males and females with nonhypermutated colorectal cancer had different trends in EP300 mutations by age group. These findings define genomic patterns of early-onset nonhypermutated colorectal cancer by race/ethnicity and sex, which yields novel biological clues into early-onset colorectal cancer disparities. SIGNIFICANCE: NHBs, but not APIs, with early-onset nonhypermutated colorectal cancer had higher adjusted tumor mutation rates versus NHWs. Differences for FLT4, FBXW7, RNF43, LRP1B, APC, PIK3CA, and ATRX mutation rates between racial/ethnic groups and EP300, KRAS, AXIN2, WRN, BRAF, and LRP1B mutation rates by sex were observed in tumors of young patients. See related commentary by Shen et al., p. 530 . This article is highlighted in the In This Issue feature, p. 517.
未加标签:大肠癌癌症差异的分子特征仍未被描述。在这里,我们研究了种族/民族和性别的体细胞突变模式,在 5856 名非西班牙裔白人(NHW)、535 名非西班牙裔黑人(NHB)和 512 名亚洲/太平洋岛民(API)结直肠癌患者中,包括 2016 名早期结直肠癌患者(测序年龄<50 岁)。与 NHW 患者相比,具有早期非超突变结直肠癌的 NHB 患者,但不是 API 患者,具有更高的调整肿瘤突变率。在早期非超突变结直肠癌中,LRP1B、FLT4、FBXW7、RNF43、ATR、APC 和 PIK3CA 突变频率在种族/民族之间存在显著差异。在 APC、FLT4 和 FAT1 之间,早期和晚期非超突变结直肠癌之间观察到种族/民族的异质性。按性别,EP300、BRAF、WRN、KRAS、AXIN2 和 SMAD2 的影响存在异质性。非超突变结直肠癌的男性和女性,其 EP300 突变的趋势按年龄组不同。这些发现定义了种族/民族和性别的早期非超突变结直肠癌的基因组模式,为早期结直肠癌差异提供了新的生物学线索。
意义:与 NHW 相比,具有早期非超突变结直肠癌的 NHB,而非 API,具有更高的调整肿瘤突变率。在年轻患者的肿瘤中观察到种族/民族之间的 FLT4、FBXW7、RNF43、LRP1B、APC、PIK3CA 和 ATRX 突变率差异,以及 EP300、KRAS、AXIN2、WRN、BRAF 和 LRP1B 突变率的性别差异。有关 Shen 等人的相关评论,请见第 530 页。本文在本期特色文章中被重点介绍,见第 517 页。
Biomarkers. 2025-2
Genome Med. 2024-8-13
Cancer Epidemiol Biomarkers Prev. 2025-8-11
Nat Rev Gastroenterol Hepatol. 2025-7-21
Cancer Causes Control. 2025-4-19
Cancers (Basel). 2025-2-28
Gastroenterol Rep (Oxf). 2025-2-20
Cancer Discov. 2022-9-2
Cancer Discov. 2022-5-2
Cancer Discov. 2022-5-2
J Natl Cancer Inst. 2022-5-9
Lancet Oncol. 2022-3
J Natl Cancer Inst. 2021-11-29
Nat Rev Cancer. 2021-6
Sci Rep. 2020-3-17
CA Cancer J Clin. 2020-3-5